Imricor Medical Systems, Inc.
ASX: IMR.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Steven Wedan
- Employees
- 78
- Headquarters
- Burnsville, United States
- IPO year
- 2019
- Market cap
- A$444.1M
- Website
- https://www.imricor.com
Loading IMR…
Loading profile data…Frequently asked questions about IMR
What does Imricor Medical Systems, Inc. (IMR.AX) do?
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an EP recording system and integrated c...
Where does IMR.AX trade?
Imricor Medical Systems, Inc. (IMR.AX) trades on the Australian Securities Exchange.
What sector is IMR.AX in?
Imricor Medical Systems, Inc. (IMR.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Imricor Medical Systems, Inc.?
Steven Wedan is the chief executive officer of Imricor Medical Systems, Inc. (IMR.AX).
Where is Imricor Medical Systems, Inc. headquartered?
Imricor Medical Systems, Inc. is headquartered in United States.
Does IMR.AX pay a dividend?
Imricor Medical Systems, Inc. (IMR.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IMR.AX go public?
Imricor Medical Systems, Inc. (IMR.AX) completed its initial public offering in 2019.